Your session is about to expire
← Back to Search
tDCS for Preventing Falls in Elderly
Study Summary
This trial will test whether a four-week intervention of personalized transcranial direct current stimulation improves dual task standing and walking performance, physical factors, and cognitive factors in older adults who report fear of falling.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have issues with moving around and keeping my balance.My Trail Making Test result is within the normal range for my age and education.I have been diagnosed with a major psychiatric condition like depression, schizophrenia, or psychosis.I cannot stand or walk by myself for a minute.I have not changed or started any sedatives, anti-psychotics, hypnotics, or antidepressants in the last month.I am 60 years old or older.You have mild or severe dementia, which is measured by a score of one or greater on a test called Clinical Dementia Rating (CDR).I was hospitalized recently due to a serious illness or injury that affects how I walk or balance.I have been diagnosed with a neurological condition like Parkinson's, Alzheimer's, MS, or had a stroke.I have had a heart attack in the last 6 months.I am currently receiving chemotherapy or radiation for my cancer.I am legally blind.I don't have seizures, use neuro-active drugs, have metal implants, or skin conditions on my scalp.I am worried about falling in the future.My physical performance score is 10 or below.Your health is not stable.I suffer from long-term dizziness.
- Group 1: Personalized tDCS
- Group 2: Active-Sham
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this trial include seniors as participants?
"Based on the listed requirements for this scientific trial, eligible individuals must be between 60 and 100 years of age."
What is the threshold for participation in this clinical investigation?
"Affirmative. According to clinicaltrials.gov, recruitment is currently underway for this medical research project which was initially posted on July 8th 2019 and updated lastly on August 1st 2022. The team needs 120 volunteers from one particular centre in order to complete the trial."
In what ways is this trial hoping to achieve its stated aims?
"This medical trial, which involves follow-ups at 3 days, 3 months and 6 months post-treatment, will measure the change from baseline in dual task cost to gait speed. Secondary objectives include measuring changes in Montreal Cognitive Assessment (MoCA) total score for global cognitive function; Hopkins Verbal Learning Test for memory; as well as dual task cost to serial subtraction performance for assessing how walking or standing affects a patient's ability to complete cognitive tasks."
Is the research project currently open to new participants?
"Affirmative. Clinicaltrials.gov attests to this trial being open for recruitment, having been posted on July 8th 2019 and last modified on August 1st 2022. 120 patients need to be sourced from a single medical centre."
What criteria must individuals meet in order to qualify for participation in this clinical trial?
"This medical investigation is open to 120 individuals aged between 60 and 100 who have aging. To qualify, participants must also meet specific criteria such as a score of 10 or less on the Short Physical Performance Battery, Trail Making Test (TMT) Part B time faster than 75% of age-and education-based norms, self-report mobility and balance issues, and admit having concern about falling in the future."
Share this study with friends
Copy Link
Messenger